Galafold drug

Ended Awarded Last action

Contract number
36C24721F0334
Awardee
Awarding agency
Obligated
$222,977

Award facts

Contract value 100% obligated
$222,977.42 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Cranbury, NJ, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00001 · Galafold drug - FSS price increase $737
Original award $222,241

About this award

This is a firm fixed price delivery order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Amicus Therapeutics US, LLC, a subsidiary of Amicus Therapeutics, Inc. The contract is for the supply of the drug Galafold (migalastat), used to treat Fabry disease, to VHA facilities and networks across the country. The contract was awarded under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule contract, which provides a mechanism for federal agencies to efficiently acquire a range of pharmaceutical products. The contract has a potential value of $222,977.42 and does not have a set-aside designation. Amicus Therapeutics US, LLC holds a five-year Pharmaceuticals and Drugs Federal Supply Schedule contract with a maximum value of $225,000, and has been awarded multiple delivery orders against this vehicle to support VHA healthcare services.

Quick answers

Who was awarded contract 36C24721F0334?

36C24721F0334 was awarded to Amicus Therapeutics US, LLC by Veterans Integrated Service Network 7 (Veterans Health Administration) on April 14, 2021.

How much is contract 36C24721F0334 worth?

The government has obligated $222,977 on 36C24721F0334.

Is contract 36C24721F0334 an order under another contract?

Yes. 36C24721F0334 is a delivery order under 36F79719D0108, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C24721F0334 competed?

The extent of competition for 36C24721F0334 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award